Banking

Crocs Earnings Beat As Sales Growth Accelerates Again

Skechers (SKX) and Crocs (CROX) both easily beat second-quarter earnings forecasts and gave strong guidance Thursday. SKX stock is poised to top a buy point, and CROX stock jumped to a new high.




X



Skechers Earnings

Estimates: Wall Street sees Skechers swinging to a profit of 52 cents a shares from a year-ago loss of 44 cents a share, as revenue soars 104% to $1.49 billion.

Results: EPS of 88 cents on revenue of $1.66 billion. Domestic wholesale sales shot up 205.7%, with international wholesale up 94.8%. Direct-to-consumer sales soared 137.8%.

Outlook: Q3 EPS of 70-75 cents, above consensus for 61 cents, on revenue of $1.6 billion-$1.65 billion, better than views for $1.51 billion. Full-year EPS of $2.55-$2.65, above consensus for $2.09, on revenue of $6.15 billion-$6.25 billion, topping views for $5.93 billion.

Stock: Shares jumped 6.6% to 54.60 late after closing up 1.9% at 151.21 Thursday. SKX stock is now positioned to clear a 51.58 buy point from a double-bottom base on a weekly chart.

Crocs Earnings

Estimates: Analysts expected Crocs earnings per share rose 56% to $1.58. They see sales jumping 68% to $557 million.

Results: Crocs earnings shot up 121% to $2.23 a share. Revenue swelled 93% to $640.8 million, the fourth straight quarter of accelerating growth.

Outlook: The footwear maker sees Q3 revenue up 60%-70%, with full-year sales up 60%-65%. Both are well above consensus.

The Colorado-based maker of foamy rubber clogs has a cult-like following among Gen Z shoppers. Crocs has partnered with pop culture favorites like Justin Bieber and Grammy-winning DJ and producer Diplo among others.

Digital sales have fueled Crocs’ revenue in recent quarters, as customers turned to online shopping during the pandemic.

Stock: Shares surged 10% to close at 131.93 on the stock market today. CROX stock broke out past a 110.01 buy point from a flat base June 23 but is now extended, according to MarketSmith chart analysis. That buy zone topped out at 115.51.

But CROX stock found support at the 10-week line, which also offered a buy point at about 109.50 with a buy range extending 10% to 120.45.

The relative strength line, which tracks performance vs. the S&P 500 index, is trending upward, approaching its all-time high. Its RS Rating is 97 out of a possible 99. Its EPS Rating is a top-notch 99, as it’s posted four straight quarters of earnings growth.

With a Composite Rating of 99, Crocs ranks No. 1 in IBD’s apparel-shoes & related manufacturing group, which itself ranks 31st among 197 groups.

Follow Adelia Cellini Linecker on Twitter @IBD_Adelia.

YOU MAY ALSO LIKE:

Why This IBD Tool Simplifies The Search For Top Stocks

Want To Get Quick Profits And Avoid Big Losses? Try SwingTrader

How To Know It’s Time To Sell Your Favorite Stock



Most Related Links :
reporterwings Governmental News Finance News

Source link

Back to top button